These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7753825)

  • 1. ETS1 suppresses tumorigenicity of human colon cancer cells.
    Suzuki H; Romano-Spica V; Papas TS; Bhat NK
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4442-6. PubMed ID: 7753825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caspase-1 is a direct target gene of ETS1 and plays a role in ETS1-induced apoptosis.
    Pei H; Li C; Adereth Y; Hsu T; Watson DK; Li R
    Cancer Res; 2005 Aug; 65(16):7205-13. PubMed ID: 16103071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A variant form of ETS1 induces apoptosis in human colon cancer cells.
    Huang CC; Papas TS; Bhat NK
    Oncogene; 1997 Aug; 15(7):851-6. PubMed ID: 9266972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The EndoA enhancer contains multiple ETS binding site repeats and is regulated by ETS proteins.
    Seth A; Robinson L; Panayiotakis A; Thompson DM; Hodge DR; Zhang XK; Watson DK; Ozato K; Papas TS
    Oncogene; 1994 Feb; 9(2):469-77. PubMed ID: 7507230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The p42 variant of ETS1 protein rescues defective Fas-induced apoptosis in colon carcinoma cells.
    Li R; Pei H; Papas T
    Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3876-81. PubMed ID: 10097131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EAPII interacts with ETS1 and modulates its transcriptional function.
    Pei H; Yordy JS; Leng Q; Zhao Q; Watson DK; Li R
    Oncogene; 2003 May; 22(18):2699-709. PubMed ID: 12743594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium-induced phosphorylation of ETS1 inhibits its specific DNA binding activity.
    Rabault B; Ghysdael J
    J Biol Chem; 1994 Nov; 269(45):28143-51. PubMed ID: 7961750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence-specific interaction of the Ets1 protein with the long terminal repeat of the human T-lymphotropic virus type I.
    Gitlin SD; Bosselut R; Gégonne A; Ghysdael J; Brady JN
    J Virol; 1991 Oct; 65(10):5513-23. PubMed ID: 1895400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ETS1, NFkappaB and AP1 synergistically transactivate the human GM-CSF promoter.
    Thomas RS; Tymms MJ; McKinlay LH; Shannon MF; Seth A; Kola I
    Oncogene; 1997 Jun; 14(23):2845-55. PubMed ID: 9190901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
    Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
    Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splicing variant DeltaVII-Ets1 is downregulated in invasive Ets1-expressing breast cancer cells.
    Ballschmieter P; Braig M; Lindemann RK; Nordheim A; Dittmer J
    Int J Oncol; 2003 Apr; 22(4):849-53. PubMed ID: 12632078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes.
    Li R; Pei H; Watson DK; Papas TS
    Oncogene; 2000 Feb; 19(6):745-53. PubMed ID: 10698492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of an enhancer of the human activating protein-2alpha gene that contains a critical Ets1 binding site.
    Cheng YH; Handwerger S
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3305-11. PubMed ID: 12843180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The biology of the Ets1 proto-oncogene.
    Dittmer J
    Mol Cancer; 2003 Aug; 2():29. PubMed ID: 12971829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase Calpha regulates Ets1 transcriptional activity in invasive breast cancer cells.
    Lindemann RK; Braig M; Ballschmieter P; Guise TA; Nordheim A; Dittmer J
    Int J Oncol; 2003 Apr; 22(4):799-805. PubMed ID: 12632071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEA3, Oct 1 and Oct 2 positively regulate the human ETS1 promoter.
    Chen JH; Wright CD
    Oncogene; 1993 Dec; 8(12):3375-83. PubMed ID: 8247540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody.
    Seth A; Robinson L; Thompson DM; Watson DK; Papas TS
    Oncogene; 1993 Jul; 8(7):1783-90. PubMed ID: 8510925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements.
    Watson DK; Robinson L; Hodge DR; Kola I; Papas TS; Seth A
    Oncogene; 1997 Jan; 14(2):213-21. PubMed ID: 9010223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ets1 is an effector of protein kinase Calpha in cancer cells.
    Vetter M; Blumenthal SG; Lindemann RK; Manns J; Wesselborg S; Thomssen C; Dittmer J
    Oncogene; 2005 Jan; 24(4):650-61. PubMed ID: 15531915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-affinity DNA-protein interactions of the cellular ETS1 protein: the determination of the ETS binding motif.
    Fisher RJ; Mavrothalassitis G; Kondoh A; Papas TS
    Oncogene; 1991 Dec; 6(12):2249-54. PubMed ID: 1766672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.